Chapter 2. Concepts of Risk Assessment: The “Process versus Product” Controversy Put to Rest

  1. Prof. Dr. H.-J. Rehm2 and
  2. Dr. G. Reed3
  1. Henry I. Miller

Published Online: 7 MAY 2008

DOI: 10.1002/9783527620999.ch2o

Biotechnology Set, Second Edition

Biotechnology Set, Second Edition

How to Cite

Miller, H. I. (2001) Concepts of Risk Assessment: The “Process versus Product” Controversy Put to Rest, in Biotechnology Set, Second Edition (eds H.-J. Rehm and G. Reed), Wiley-VCH Verlag GmbH, Weinheim, Germany. doi: 10.1002/9783527620999.ch2o

Editor Information

  1. 2

    Institut für Mikrobiologie, Universität Münster, Corrensstraße 3, D-4400 Münster

  2. 3

    2131 N. Summit Ave., Apartment #304, Milwaukee, WI 53202-1347, USA

Author Information

  1. Stanford, CA 94305–6010, USA

Publication History

  1. Published Online: 7 MAY 2008
  2. Published Print: 10 MAY 2001

ISBN Information

Print ISBN: 9783527257621

Online ISBN: 9783527620999

SEARCH

Keywords:

  • biotechnology;
  • genetic engineering;
  • excessive regulation;
  • laboratory research;
  • bureaucracy

Summary

The prelims comprise:

  • Introduction

  • The Myths of Biotechnology

  • The Basis for Risk Assessment for the New Biotechnology: Product, Not Process

  • The Status of Regulation in the United States

  • Implications for Public Policy

  • Conclusions

  • References